Indeed, methodological advances have recently enabled to identify the presence of citrullinated antigen-specific B cells (i.e., ACPA-expressing, IgG or IgA) (175–177), plasmablasts (178–180), and plasma cells (181) at relatively high levels in the peripheral blood of RA patients. The gene discussed is CD79A; the disease is rheumatoid arthritis.